المؤلفون: Zeijlemaker, W, Kelder, A, Oussoren-Brockhoff, Y J M, Scholten, W J, Snel, A N, Veldhuizen, D, Cloos, J^{Aff1, Aff2}, Ossenkoppele, G J, Schuurhuis, G J^{Aff1, IDleu2015255_cor9}

المصدر: Leukemia. 30(3):708-715

المؤلفون: Zeijlemaker, W, Kelder, A, Oussoren-Brockhoff, Y J M, Scholten, W J, Snel, A N, Veldhuizen, D, Cloos, J^{Aff1, Aff2}, Ossenkoppele, G J, Schuurhuis, G J^{Aff1, IDleu2015252_cor9}

المصدر: Leukemia. 30(2):439-446

المؤلفون: Zeijlemaker, W., Meijer, R., Kelder, A., Carbaat-Ham, J., Oussoren-brockhoff, Y., Snel, S., Veldhuizen, D., Scholten, W., Maertens, J., Breems, D., Pabst, T., Manz, M., Van der Velden, V., Slomp, J., Valk, P., Cloos, J., Lowenberg, B., Ossenkoppele, G., Schuurhuis, G. J.

المساهمون: CCA - Imaging and biomarkers, Hematology laboratory, Hematology

المصدر: Haematologica, 102, 7-8. Ferrata Storti Foundation
Zeijlemaker, W, Meijer, R, Kelder, A, Carbaat-Ham, J, Oussoren-brockhoff, Y, Snel, S, Veldhuizen, D, Scholten, W, Maertens, J, Breems, D, Pabst, T, Manz, M, Van der Velden, V, Slomp, J, Valk, P, Cloos, J, Lowenberg, B, Ossenkoppele, G & Schuurhuis, G J 2017, ' LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY ', Haematologica, vol. 102, pp. 7-8 .

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f8515beed5f976fea07915d6a81557ac
https://research.vumc.nl/en/publications/08b5a729-d702-4e0f-8323-80bff0bf497f

المؤلفون: Versluis, J., Kalin, B., Zeijlemaker, W., Passweg, J., Graux, C., Manz, M., Vekemans, M-C, Biemond, B., Legdeur, M-C, Kooy, M. van Marwijk, Janssen, J., Pabst, T., Lowenberg, B., Jongen-Lavrencic, M., Schuurhuis, G. J., Ossenkoppele, G., Cornelissen, J.

المساهمون: Hematology laboratory, CCA - Cancer Treatment and quality of life, Hematology

المصدر: Haematologica, 102, 7-7. Ferrata Storti Foundation
Versluis, J, Kalin, B, Zeijlemaker, W, Passweg, J, Graux, C, Manz, M, Vekemans, M-C, Biemond, B, Legdeur, M-C, Kooy, M V M, Janssen, J, Pabst, T, Lowenberg, B, Jongen-Lavrencic, M, Schuurhuis, G J, Ossenkoppele, G & Cornelissen, J 2017, ' GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION ', Haematologica, vol. 102, pp. 7-7 .

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::eb8d0599a5fde15ce9444a3c78ab9331
https://research.vumc.nl/en/publications/0c2c6296-9940-4939-9ce1-df11ebf00ced

المؤلفون: Zeijlemaker, W.

المساهمون: Ossenkoppele, Gert, Schuurhuis, Gerrit, Hematology laboratory, CCA - Cancer biology and immunology, Ossenkoppele, G.J., Schuurhuis, G.J.

مصطلحات موضوعية: minimal/measurable residual disease, acute myeloid leukemia, leukemic stem cells

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0b447a066a41978e32b07bd384527c35
https://research.vumc.nl/en/publications/0f85b8cb-1330-4886-bbd0-85009c81ab02

المؤلفون: Zeijlemaker, W

المصدر: Zeijlemaker, W 2017, ' Leukemic stem cells and measurable residual disease in AML : An emerging new outcome parameter ', PhD, Vrije Universiteit Amsterdam .
Zeijlemaker, W 2017, ' Leukemic stem cells and measurable residual disease in AML : An emerging new outcome parameter ', Doctor of Philosophy, VU Vrije Universiteit . < http://hdl.handle.net/1871.1/7e5b2666-8a23-4d19-94e1-9c5fe2c74e33 >

مصطلحات موضوعية: minimal/measurable residual disease, acute myeloid leukemia, leukemic stem cells

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f3054f601965acb176716780cb093f9c

المؤلفون: Lansdorp, P. M., van der Kwast, T. H., van Mourik, P., Zeijlemaker, W. P.

المساهمون: Bernard, Alain, editor^Aff1, Boumsell, Laurence, editor^Aff2, Dausset, Jean, editor^Aff3, Milstein, César, editor^Aff4, Schlossman, Stuart F., editor^Aff5

المصدر: Leucocyte Typing : Human Leucocyte Differentiation Antigens Detected by Monoclonal Antibodies. Specification — Classification — Nomenclature. :488-492

المؤلفون: Lansdorp, P. M., Bauman, J. G. J., Zeijlemaker, W. P.

المساهمون: Reinherz, Ellis L., editor^Aff1, Nadler, Lee M., editor^Aff1, Haynes, Barton F., editor^Aff2, Bernstein, Irwin D., editor^Aff3

المصدر: Leukocyte Typing II : Volume 3 Human Myeloid and Hematopoietic Cells. :285-294

Degree: M.D.

المؤلفون: Schuurhuis, G.J., Zeijlemaker, W, Cloos, J

المساهمون: Hematology laboratory, CCA - Treatment and quality of life, CCA - Imaging and biomarkers, CCA - Cancer biology and immunology

المصدر: Schuurhuis, G J, Zeijlemaker, W & Cloos, J 2015, Flow cytometric MRD and leukemia stem cell frequency assessment to develop risk-stratified approaches in AML . in Annals of Hematology . Annals of Hematology, vol. 94, Springer Verlag, G.J. Schuurhuis, Department of Hematology, Amsterdam, Netherlands, pp. S49-S51 . < http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71868790 >
Annals of Hematology, S49-S51
STARTPAGE=S49;ENDPAGE=S51;TITLE=Annals of Hematology

مصطلحات موضوعية: hemic and lymphatic diseases

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0b0d802ecd62315fd4681dfd0c3cf9c2
https://research.vumc.nl/en/publications/b94d6d9d-c1f9-4634-8b43-57e02b5c171f

المؤلفون: Zeijlemaker, W., Gratama, J.W., Schuurhuis, G.J.

المساهمون: Hematology laboratory, CCA - Disease profiling

المصدر: Cytometry Part B. Clinical Cytometry, 86(1), 3-14. Wiley-Liss Inc.
Zeijlemaker, W, Gratama, J W & Schuurhuis, G J 2014, ' Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease ', Cytometry Part B. Clinical Cytometry, vol. 86, no. 1, pp. 3-14 . https://doi.org/10.1002/cyto.b.21134

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1dfdd4e6f19deb03e45f668104250adf
https://research.vumc.nl/en/publications/3d22a3f7-3e2b-46c9-88d9-ab5d6a5c8ef5